Itm Solucin Gmbh

This early-stage trial tests a radioactive drug (Lu-177 edotreotide) in children aged 2 to 17 with cancers that have a specific marker (SSTR-positive). The goal is to find the right dose and check safety. About 20 children whose cancer has returned or not responded to prior treat…

This program gives eligible patients with meningioma access to the investigational drug ITM-11 before it is officially approved. The treating doctor decides if the possible benefits outweigh the risks. The program is only available in certain countries.